Enlivex Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENLV and other ETFs, options, and stocks.

About ENLV

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.

CEO

Oren Hershkovitz

CEOOren Hershkovitz

Employees

Employees36

Headquarters

Ness Ziona, Tel Aviv

HeadquartersNess Ziona, Tel Aviv

Founded

2012

Founded2012

Employees

Employees36

ENLV Key Statistics

Market cap

25.41M

Market cap25.41M

Price-Earnings ratio

-1.89

Price-Earnings ratio-1.89

Dividend yield

—

Dividend yield—

Average volume

221.45K

Average volume221.45K

High today

$1.09

High today$1.09

Low today

$1.05

Low today$1.05

Open price

$1.07

Open price$1.07

Volume

142.96K

Volume142.96K

52 Week high

$2.10

52 Week high$2.10

52 Week low

$0.8101

52 Week low$0.8101

ENLV News

TipRanks 5d

Enlivex Announces Positive Phase IIa Results for Allocetra™ in Knee Osteoarthritis

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own ENLV. This list is generated using Robinhood data, and it’s not a recommendation.